From the Journals

Obesity can shift severe COVID-19 to younger age groups


 

Sensitivity needed in public messaging about risks, but test sooner

With an obesity rate of about 40% in the United States, the results are particularly relevant for Americans, Kass and Heymsfield say, noting that the country’s “obesity belt” runs through the South.

Heymsfield, who wasn’t part of the new analysis, notes that public messaging around severe COVID-19 risks to younger adults with obesity is “tricky,” especially because the virus is “still pretty common in nonobese people.”

Kass agrees, noting, “it’s difficult to turn to 40% of the population and say: ‘You guys have to watch it.’ ”

But the mounting research findings necessitate linking obesity with severe COVID-19 disease and perhaps testing patients in this category for the virus sooner before symptoms become severe.

And of note, since shortness of breath is common among people with obesity regardless of illness, similar COVID-19 symptoms might catch these individuals unaware, pointed out Heymsfield, who is also a professor in the Metabolism and Body Composition Lab at Pennington Biomedical Research Center at Louisiana State University, Baton Rouge.

“They may find themselves literally unable to breathe, and the concern would be that they wait much too long to come in” for treatment, he said. Typically, people can deteriorate between day 7 and 10 of the COVID-19 infection.

Individuals with obesity “need to be educated to recognize the serious complications of COVID-19 often appear suddenly, although the virus has sometimes been working its way through the body for a long time,” he concluded.

Kass and Heymsfield have declared no relevant financial relationships.

This article first appeared on Medscape.com.

Pages

Recommended Reading

Survey puts a price on health improvement
MDedge Hematology and Oncology
A cigarette in one hand and a Fitbit on the other
MDedge Hematology and Oncology
Bariatric surgery candidates show high prevalence of thrombophilia
MDedge Hematology and Oncology
Evidence builds for bariatric surgery’s role in cancer prevention
MDedge Hematology and Oncology
Lorcaserin withdrawn from U.S. market due to cancer risk
MDedge Hematology and Oncology
Adolescent obesity linked with midlife cancer risk
MDedge Hematology and Oncology
Bariatric surgery may curtail colorectal cancer risk
MDedge Hematology and Oncology
COVID-19 cases highlight longstanding racial disparities in health care
MDedge Hematology and Oncology
COVID-19 pandemic spells trouble for children’s health
MDedge Hematology and Oncology
Obesity link to severe COVID-19, especially in patients aged under 60
MDedge Hematology and Oncology